The AARS1 gene CMT2N genetic test is a specialized diagnostic procedure designed to identify mutations in the AARS1 gene, which are associated with Charcot-Marie-Tooth disease type 2N (CMT2N). CMT2N is a subtype of Charcot-Marie-Tooth disease, a group of inherited neurological disorders that affect the peripheral nerves. These mutations lead to issues with nerve function, causing symptoms such as muscle weakness, decreased muscle size, reduced sensation, and in some cases, foot deformities.
This genetic test is crucial for individuals showing symptoms of CMT2N, as it helps in confirming the diagnosis, understanding the progression of the disease, and making informed decisions regarding management and treatment options. Additionally, the test can provide valuable information for family planning and genetic counseling for affected families.
The test is performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the AARS1 gene CMT2N genetic test is 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or cheek swab, and comprehensive analysis in the laboratory to detect any mutations in the AARS1 gene. Results from the test can help guide personalized treatment plans and offer insights into the prognosis of the condition.
The LRSAM1 gene CMT2P genetic test is a specialized diagnostic procedure designed to identify mutations in the LRSAM1 gene, which are associated with Charcot-Marie-Tooth disease type 2P (CMT2P). CMT2P is a subtype of Charcot-Marie-Tooth disease, a group of inherited neurological disorders that affect the peripheral nerves. These disorders are characterized by muscle weakness and atrophy, sensory loss, and in some cases, foot deformities.
The test is performed by analyzing the patient's DNA to detect mutations in the LRSAM1 gene that are known to cause CMT2P. This genetic testing is crucial for accurate diagnosis, which can aid in the management and treatment of the condition. It can also provide valuable information for family planning and genetic counseling for affected families.
The cost of the LRSAM1 gene CMT2P genetic test is 3200 AED. The test is available at DNA Labs UAE, a leading laboratory that specializes in genetic testing and analysis. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetics, ensuring high-quality and reliable test results. By opting for this test at DNA Labs UAE, patients and their families can gain insights into their genetic health, enabling them to make informed decisions about their care and future.
The CTDP1 gene is associated with a specific form of Charcot-Marie-Tooth disease (CMT4), a group of inherited disorders that affect the peripheral nerves. These nerves carry signals between the brain and muscles, enabling movements and sensations. Mutations in the CTDP1 gene can lead to a subtype of CMT known as CMT4, characterized by weakness and atrophy of the muscles, particularly in the feet and legs, often leading to difficulties in walking and a high-stepped gait.
To diagnose this condition, genetic testing for the CTDP1 gene can be crucial. In the UAE, DNA Labs offers a specialized genetic test to identify mutations in the CTDP1 gene that are related to CMT4. This test is vital for individuals showing symptoms of CMT4 or those with a family history of the disease, as it can provide a definitive diagnosis.
The cost of the CTDP1 gene test at DNA Labs UAE is 4400 AED. This investment covers the collection of a DNA sample, usually through a blood draw or cheek swab, and its subsequent analysis in the laboratory. The results from this test can inform patients and their healthcare providers about the genetic basis of their condition, guiding treatment decisions and helping to predict the course of the disease. Additionally, knowing one's genetic status can be important for family planning and understanding the risk of passing the condition on to future generations.
The GDAP1 Gene CMT4A Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the GDAP1 gene, which are responsible for Charcot-Marie-Tooth disease type 4A (CMT4A). CMT4A is a rare subtype of Charcot-Marie-Tooth disease, a group of hereditary disorders that affect the peripheral nerves, leading to muscle weakness and sensory problems, primarily in the arms and legs. The GDAP1 gene plays a crucial role in the functioning of peripheral nerves, and mutations in this gene disrupt nerve transmission, causing the symptoms associated with CMT4A.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing, ensuring high standards of accuracy and reliability. With a cost of 4400 AED, the GDAP1 Gene CMT4A Genetic Test is an essential tool for individuals with a family history of Charcot-Marie-Tooth disease or those exhibiting symptoms consistent with peripheral neuropathies. Early and accurate diagnosis through this genetic test can aid in the management of the condition, allowing for targeted interventions and informed genetic counseling for affected families.
The MTMR2 gene CMT4B1 genetic test is a specialized diagnostic tool used to detect mutations in the MTMR2 gene, which are associated with Charcot-Marie-Tooth disease type 4B1 (CMT4B1). This condition is a rare, inherited, neurological disorder characterized by the degeneration of peripheral nerves, leading to muscle weakness and sensory loss, typically starting in the limbs. The test involves analyzing the patient's DNA to identify any genetic alterations in the MTMR2 gene that may indicate the presence of CMT4B1.
This genetic test is crucial for individuals who exhibit symptoms suggestive of Charcot-Marie-Tooth disease or have a family history of the condition, as it helps in confirming the diagnosis, understanding the disease progression, and making informed decisions about management and treatment options. Early diagnosis through genetic testing can significantly improve the quality of life for affected individuals by facilitating timely interventions and support.
The MTMR2 gene CMT4B1 genetic test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to accurately interpret the results. By choosing DNA Labs UAE for this test, patients can expect high-quality services, accurate results, and comprehensive support throughout the testing process.
The "SBF2 Gene CMT4B2 Genetic Test" is a specific diagnostic procedure aimed at detecting mutations in the SBF2 gene, which are responsible for Charcot-Marie-Tooth disease type 4B2 (CMT4B2). Charcot-Marie-Tooth disease is a group of inherited disorders that affect the peripheral nerves, leading to muscle weakness and atrophy, as well as sensory problems. The SBF2 gene plays a crucial role in the development and maintenance of myelin, the protective sheath surrounding nerve fibers. Mutations in this gene disrupt myelin integrity, impairing nerve function and leading to the symptoms associated with CMT4B2.
This genetic test is a vital tool for diagnosing CMT4B2, allowing for precise genetic counseling and aiding in the development of targeted treatment plans for affected individuals. The test involves collecting a DNA sample, typically through a blood draw, which is then analyzed in a laboratory setting to identify mutations in the SBF2 gene.
The cost of the "SBF2 Gene CMT4B2 Genetic Test" is 4400 AED. It is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable test results. This test is an important resource for individuals with a family history of Charcot-Marie-Tooth disease, offering them crucial information about their genetic health and helping guide their healthcare decisions.
The SH3TC2 gene CMT4C genetic test is a specialized diagnostic tool used to detect mutations in the SH3TC2 gene, which are associated with Charcot-Marie-Tooth disease type 4C (CMT4C). CMT4C is a rare form of Charcot-Marie-Tooth disease, a group of disorders that affect the peripheral nerves, leading to muscle weakness and sensory problems primarily in the arms and legs. The test is crucial for confirming the diagnosis, understanding the disease progression, and making informed decisions about management and treatment options.
Performed at DNA Labs UAE, this genetic test involves collecting a DNA sample, usually through a blood draw or a cheek swab, and analyzing the SH3TC2 gene for specific mutations. The accuracy and reliability of the test make it a valuable resource for affected individuals and their families.
The cost of the SH3TC2 gene CMT4C genetic test at DNA Labs UAE is 4400 AED. This investment can provide essential information for the clinical management of patients with or at risk of developing CMT4C, enabling early intervention and personalized care plans to improve quality of life.
The NDRG1 Gene CMT4D Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the NDRG1 gene, which are linked to Charcot-Marie-Tooth disease type 4D (CMT4D). CMT4D is a rare form of hereditary motor and sensory neuropathy, characterized by significant nerve damage, leading to muscle weakness and atrophy, sensory loss, and in severe cases, disability. Early detection through genetic testing is crucial for managing symptoms, planning treatment strategies, and providing genetic counseling for affected families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the NDRG1 gene. The process is highly accurate, providing individuals and healthcare professionals with vital information on the genetic basis of the condition.
The cost of the NDRG1 Gene CMT4D Genetic Test is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be overstated, as it opens the door to targeted interventions and supports better clinical outcomes for patients with this genetic condition.
The "VLDLR Gene Cerebellar Hypoplasia and Mental Retardation with or without Quadrupedal Locomotion Type 1 Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect mutations in the VLDLR gene. These mutations are associated with a rare genetic disorder characterized by underdevelopment of the cerebellum (cerebellar hypoplasia), intellectual disability, and in some cases, an unusual pattern of movement that may include walking on all fours (quadrupedal locomotion). The test plays a crucial role in confirming the diagnosis, allowing for a better understanding of the condition, and facilitating appropriate management and support strategies for affected individuals and their families. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the presence of mutations in the VLDLR gene.
The CST3 Gene Cerebral Amyloid Angiopathy Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the CST3 gene, which are linked to an increased risk of cerebral amyloid angiopathy (CAA). CAA is a neurological condition characterized by the accumulation of amyloid proteins in the walls of the blood vessels in the brain, leading to various complications such as hemorrhagic stroke, dementia, and cognitive decline. The test is particularly crucial for individuals with a family history of CAA or related symptoms, as early detection can significantly aid in managing the condition and tailoring appropriate treatment strategies. Priced at 4400 AED, this genetic test offers a valuable tool for patients and healthcare providers to understand the genetic predisposition to CAA, enabling proactive healthcare measures. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing outcomes, contributing to the advancement of personalized medicine in the region.
